Rights and permissions
About this article
Cite this article
Infliximab worth it for ankylosing spondylitis in Canada . . .. Pharmacoecon. Outcomes News 483, 7 (2005). https://doi.org/10.2165/00151234-200504830-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504830-00014